HaitiDocs

Data / Partner portfolio / Gates Foundation

Investigations on the effectiveness of Oral Cholera Vaccine

Published title: Investigations in Haiti on the effectiveness of Oral Cholera Vaccine

US$ millions unless stated. Haitian fiscal year, October to September. FY2026-27 began October 1, 2026.

Description

to generate evidence on OCV effectiveness through studies in Haiti on a single-dose of OCV in children and on the duration of protection of OCV in adults through a follow-up of in a case-control study.

Partner
Gates Foundation
Sector
Health
Stage
Closed since July 25, 2025
Start
September 27, 2023
Closing
July 25, 2025
Effectiveness
Not reported
Last transaction
September 27, 2023
IATI identifier
DAC-1601-INV-057525
Life cycle4 stages, 7 dates

Stage history

StageFrom
ApprovedSeptember 27, 2023
Under waySeptember 27, 2023
ClosingSeptember 19, 2024
ClosedJuly 25, 2025

Dates

EventDateSource
Actual startSeptember 27, 2023IATI
First commitmentSeptember 27, 2023Transactions
First disbursementSeptember 27, 2023Transactions
Last disbursementSeptember 27, 2023Transactions
Planned startSeptember 27, 2023IATI
Planned closing dateSeptember 19, 2024IATI
Actual closing dateJuly 25, 2025IATI

Financing

Table 1.Position at the data date by source (stocks), US$ millions

This pageUS$ millionsSource
Commitment0.3IATI
Disbursed0.3IATI
UndisbursedNot reported
Total costNot reported

IATI amounts. Approved: The commitments the partner reports, converted to US$. Disbursed to date: The disbursements (IATI transaction type 3, funds paid to another organization) and expenditure (type 4, funds spent by the publisher) the partner reports, converted to US$. Undisbursed: The undisbursed balance the record gives, where the partner reports one, in US$. Amounts by source

Changes to the operationnot reported
Original closing date
Not reported
Closing date extensions
Not reported
Restructurings
Not reported
Emergency component
Not reported

New commitments and disbursements by fiscal year

Table 2.New commitments and disbursements by fiscal year (flows), US$ millions

FY2022-23US$ millions
New commitments0.3
Disbursements0.3
Cumulative disbursements0.3

Records and documents

Transactions2 transactions, September 27, 2023 to September 27, 2023

Table 3.Transactions, US$ millions

DateMeasureAmountUS$ millionsSourceMethod
September 27, 2023Commitment0.3IATIIATI commitment (transaction type 2)
September 27, 2023Disbursements0.3IATIIATI disbursement (transaction type 3), paid to another organization
Terms6 of 6 reported
Finance type
110 Standard grant
Flow type
30 Private development finance
Aid type
C01 Project-type interventions
Tied status
5 Untied
Collaboration type
6 Private development finance
Humanitarian
No
Policy markers7 policy markers
Policy markerSignificanceSource
Gender equalityNot targetedIATI
Disaster risk reductionNot targetedIATI
NutritionNot targetedIATI
Climate change adaptationNot targetedIATI
Reproductive, maternal, newborn and child healthNot targetedIATI
SDG 17 Partnerships for the goalsNot reportedIATI
SDG 3 Good health and well-beingNot reportedIATI
Locations1 place named
DepartmentsNot reported
Places named by the sourceHaiti
Places with coordinates0
Funds transferred onward2 transactions
RecipientTransactionDateUS$ millions
Massachusetts General HospitalCommitmentSeptember 27, 20230.3
Massachusetts General HospitalDisbursementSeptember 27, 20230.3
Identifiers1 identifier
SystemIdentifierSource
IATI identifierDAC-1601-INV-057525IATI
Partner documents18 documents
Procurement notices (2)

Sources

Data as of October 18, 2026
SourceAccessed on
IATIOctober 18, 2026
IATIOctober 18, 2026
Cite this page

HaitiDocs. Investigations on the effectiveness of Oral Cholera Vaccine. Partner portfolio, data as of October 18, 2026. https://www.haitidocs.org/portfolio/projects/IATI%3ADAC-1601-INV-057525